Unlearn

San Francisco, United States Founded: 2017 • Age: 9 yrs
Provider of AI-based clinical trial management software

About Unlearn

Unlearn is a company based in San Francisco (United States) founded in 2017.. Unlearn has raised $127.13 million across 6 funding rounds from investors including Mubadala, Invest Northern Ireland and Altimeter Capital. Unlearn offers products and services including Unlearn Platform and Digital Twin Generators. Unlearn operates in a competitive market with competitors including Ebenbuild, adsilico, Verto Health, ELEM Biotech and Virtonomy, among others.

  • Headquarter San Francisco, United States
  • Sectors
    Technology
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Unlearn.Ai, Inc.
Operational Areas
Technology → Internet of Things (IoT) & Connectivity
Healthcare → Biotechnology, Genomics & Life Sciences Research
Technology → Artificial Intelligence & Machine Learning
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $127.13 M (USD)

    in 6 rounds

  • Latest Funding Round
    $50 M (USD), Series C

    Jan 25, 2024

  • Investors
    Mubadala

    & 14 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Unlearn

Unlearn offers a comprehensive portfolio of products and services, including Unlearn Platform and Digital Twin Generators. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Generates digital twins for simulating patient outcomes in clinical trials.

Tools for predicting clinical variables and enhancing trial efficiency.

People of Unlearn
Headcount 10-50
Employee Profiles 26
Board Members and Advisors 5
Employee Profiles
People
Andrew Stelzer
Head of Business Development
People
Tracey Murphy
Financial Controller
People
Jeroen Kools
Senior Software Engineer
People
Aaron Smith
Head of Machine Learning

Unlock access to complete

Board Members and Advisors
people
Mira Murati
Director
people
Ann Taylor
Director
people
Eric Shiozaki
Director
people
Francisco Gimenez
Director

Unlock access to complete

Funding Insights of Unlearn

Unlearn has successfully raised a total of $127.13M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $50 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 6
  • Last Round Series C — $50.0M
  • First Round

    (30 Jan 2020)

  • Investors Count 15
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Series C - Unlearn Valuation Altimeter Capital
Mar, 2023 Amount Series B - Unlearn Valuation Radical Ventures , Wittington Ventures
Apr, 2022 Amount Series B - Unlearn Valuation Global Ventures , Insight Partners
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Unlearn

Unlearn has secured backing from 15 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Mubadala, Invest Northern Ireland and Altimeter Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Long/short equity hedge fund and VC fim
Founded Year Domain Location
Venture capital firm focused on AI-driven companies
Founded Year Domain Location
Wittington Ventures is engaged in investing in technology start-ups.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Unlearn

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Unlearn

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Unlearn Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Unlearn

Unlearn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ebenbuild, adsilico, Verto Health, ELEM Biotech and Virtonomy, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital twin-based precision therapy for ARDS ventilation is provided.
domain founded_year HQ Location
In-silico trial solutions for medical device testing are developed.
domain founded_year HQ Location
A digital twin platform for population health management is offered.
domain founded_year HQ Location
A simulation-based platform for virtual medical trials is provided.
domain founded_year HQ Location
Virtual patient simulations are provided for medical device development.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Unlearn

Frequently Asked Questions about Unlearn

When was Unlearn founded?

Unlearn was founded in 2017 and raised its 1st funding round 3 years after it was founded.

Where is Unlearn located?

Unlearn is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

Who is the current CEO of Unlearn?

Steven Herne is the current CEO of Unlearn.

Is Unlearn a funded company?

Unlearn is a funded company, having raised a total of $127.13M across 6 funding rounds to date. The company's 1st funding round was a Series B of $50M, raised on Jan 30, 2020.

What does Unlearn do?

Provider of AI-based clinical trial management software. It uses Artificial-Intelligence control arm in a trial to enable sponsors to reduce the number of subjects. The product digital twins is a computationally generated clinical record that describes what would have happened if a specific subject had received a procedure prescribed for the psychological benefit of the patient.

Who are the top competitors of Unlearn?

Unlearn's top competitors include Ebenbuild, Verto Health and Virtonomy.

What products or services does Unlearn offer?

Unlearn offers Unlearn Platform and Digital Twin Generators.

Who are Unlearn's investors?

Unlearn has 15 investors. Key investors include Mubadala, Invest Northern Ireland, Altimeter Capital, Radical Ventures, and Wittington Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available